MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. (Q39343253)

11 September 2017

title

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. (English)

1 reference

11 September 2017

1 reference

Laisheng Li

1

1 reference

11 September 2017

Linjin Yuan

2

1 reference

11 September 2017

Jinmei Luo

3

1 reference

11 September 2017

Jie Gao

4

1 reference

11 September 2017

Jiaoli Guo

5

1 reference

11 September 2017

Xiaoming Xie

6

1 reference

11 September 2017

publication date

24 May 2012

1 reference

Clinical and Experimental Medicine

11 September 2017

published in

1 reference

11 September 2017

volume

13

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

109-117

1 reference

MicroRNAs: target recognition and regulatory functions

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MicroRNA expression profiling of male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-34a expression, cell cycle arrest and cell death of malignant mesothelioma cells upon treatment with radiation, docetaxel or combination treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Development of microRNA-145 for therapeutic application in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MicroRNA biogenesis: coordinated cropping and dicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Unravelling the complexity of metastasis - molecular understanding and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Myc overexpression brings out unexpected antiapoptotic effects of miR-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-012-0186-5

10.1007/S10238-012-0186-5

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference